Davita Calls Whistleblowers' FCA Kidney Drugs Suit Flawed
Davita Inc. urged a Georgia federal court on Thursday to toss a whistleblower suit alleging it bilked taxpayers by seeking reimbursement for intentionally overused or wasted dialysis drugs, saying its dosing...To view the full article, register now.
Already a subscriber? Click here to view full article